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Abstract
Monozygotic (MZ) twin studies constitute a key resource for the dissection of environmental 
and biological risk factors for human complex disorders. Given that epigenetic differences 
accumulate throughout the lifespan, the assessment of MZ twin pairs discordant for depression 
offers a genetically informative design to explore DNA methylation while accounting for the 
typical confounders of the field, shared by co-twins of a pair. In this review, we systematically 
evaluate all twin studies published to date assessing DNA methylation in association with 
depressive phenotypes. However, difficulty to recruit large numbers of MZ twin pairs fails to 
provide enough sample size to develop genome-wide approaches. Alternatively, region and 
pathway analysis revealed an enrichment for nervous system related functions; likewise, 
evidence supports an accumulation of methylation variability in affected subjects when 
compared to their co-twins. Nevertheless, longitudinal studies incorporating known risk factors 
for depression such as childhood trauma are required for understanding the role that DNA 
methylation plays in the etiology of depression.  
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1. Background
The study of monozygotic twins has been instrumental in virtually all complex disorders (van 
Dongen et al., 2012) but specially so in the field of psychiatry. Far-reaching psychiatric research 
has been conducted using human twins. Perhaps the first studies on this topic using scientific 
methodologies were conducted in the 19th century by Savage (1883) and Gill (1883), by 
examining a couple of cases of mania and melancholia. Twin studies initially allowed to 
determine the heritability of complex traits but have since evolved to aid in the search for 
biomarkers of disease (Polderman et al., 2015; van Dongen et al., 2012; Young et al., 2017). This 
approach has proven especially useful in complex disorders characterized by considerable 
environmental influences, as is the case for psychiatric illness. 
Major Depressive Disorder (MDD) is the non-communicable disease with the highest impact 
worldwide (Friedrich, 2017). Unipolar depressive disorders have been predicted to be the 
second leading cause of disease burden worldwide by 2030 and the first in high-income 
countries (Mathers & Loncar, 2006). Furthermore, MDD exhibits one of the lowest heritability 
values (around 40-50% depending on the study) of all psychiatric disorders suggesting a major 
role for environmental factors in  triggering the disorder (Kenneth S Kendler et al., 2018). Indeed, 
several twin studies have documented the risk to develop psychiatric symptoms after exposure 
to stressful life events and traumatic experiences, such as childhood maltreatment or bullying 
(Arseneault et al., 2011; K S Kendler & Halberstadt, 2013; Silberg et al., 2016).
Due to both its low heritability and the heterogeneity of its clinical manifestations, the search 
for genetic risk variants for depressive phenotypes has proven extremely challenging. Recently, 
a genome-wide meta-analysis encompassing more than 800,000 subjects from three different 
cohorts yielded 102 significant risk loci (Howard et al., 2018). Interestingly, this study took into 
account broader definitions of depression; e.g. self-reported clinical diagnosis of depression and 
self-reported help-seeking for problems with nerves, anxiety, tension or depression. Likewise, 
the genetic architecture of depression seems to greatly overlap with that of neuroticism 
highlighting the fact that more dimensional approaches are required in the field (Nagel et al., 
2018).
The development of animal models for psychopathological conditions remains challenging due 
to the complexity and inherently human nature of psychiatric symptomatology. That is why 
monozygotic twins emerge as quasi-experimental models to dissect the effects of the 
environment in genetically identical human subjects who have been raised in similar conditions 
(shared environment). While monozygotic (MZ) twins origin from a single zygote that splits into 
two individuals in the early stages of embryonic development, dizygotic (DZ) twins origin from 
different zygotes; thus, MZ twins share virtually 100% of their genetic sequence while DZ twins 
only share approximately 50%. In fact, somatic mutations occurring at the earliest stages of 
embryonic development have been described in MZ twins (Li et al., 2014); however, MZ twins 
are considered as identical for research purposes given the low frequency of those mutations.  
Interestingly, the simultaneous study of MZ and DZ twins allows the disentangling of the role of 
non-shared (or unique) environment in the etiology of several complex traits and disorders 
(Figure 1).
Such non-shared environmental influences start as early as during the prenatal stages of life 
where intrauterine factors differentially affect co-twins of the same MZ pair (e.g. unequal 
placental distribution). Interestingly, MZ twins can share or not their chorion and amnion 
depending on the timing of the twinning process (Hall, 2003). Thus, MZ twins can be classified 
in diamniotic dichorionic, diamniotic monochorionic and monoamniotic monochorionic, 
respectively. Notably, monochorionic MZ twins exhibited higher epigenetic discordance than 
dichorionic MZ twins, suggesting that sharing the chorion involves a higher struggle for 
resources (Gordon et al., 2012; Palma-Gudiel et al., 2019).
Known risk factors for psychiatric disorders such as urbanicity, the loss of a parent, or low 
socioeconomic status are all shared environmental influences between MZ twins who have been 
raised together. Likewise, MZ twins share biological factors that are typically difficult to 
disentangle from psychopathology, such as gender, age and genotype. Thus, the study of MZ 
twins discordant for disease states allows the identification of novel biomarkers and gene 
pathways involved in the etiology of a certain trait of interest. 
Epigenetic modifications might mediate the effects of non-shared environment on differential 
vulnerability for complex disorders. Briefly, epigenetics refers to heritable and dynamic chemical 
modifications modulating gene expression without altering the genetic sequence. DNA 
methylation is one of the most explored epigenetic mechanisms due to its accessibility, inter-
individual variability and temporal stability (Talens et al., 2010). Unlike genetic variability, DNA 
methylation is dynamic and tissue-specific; thus, transversal studies do not allow establishing 
causal mechanisms while the tissue of interest is usually inaccessible (Mill & Heijmans, 2013). 
Although identical in their genetic sequences, MZ twins diverge at the epigenetic level. Notably, 
epigenetic differences between twins of a pair accumulate throughout the lifespan suggesting 
the epigenome has the capacity to respond and adapt to the surrounding environment (Fraga 
et al., 2005). In this context, epigenetic discordance between MZ twins emerges as a tool to 
better understand the etiology of depression (Bell & Spector, 2011).
MZ twin study designs offer a unique opportunity to unravel the epigenetic basis of depressive 
phenotypes by means of the exploration of discordant pairs. Thus, the main goals of this review 
are (i) to systematically assess all research papers assessing DNA methylation correlates of 
depression by means of MZ twin studies, and (ii) analyze the advantages and disadvantages of 
each of the methodologies reviewed. 
2. Methodology
2.1. Selection criteria
A systematic literature search was conducted in September 2019 in the PUBMED and SCOPUS 
databases, and the reference lists of the papers collected therein. The search items were limited 
to the title and abstract. The keywords combination was: (twin*) AND (depression OR 
depressive) AND (epigenetic* OR methylation). See Figure 2 for a flow diagram of the literature 
search and selection of papers to be included in the present review. The search yielded 14 
papers to be reviewed (Byrne et al., 2013; A. Córdova-Palomera et al., 2015; A Córdova-
Palomera et al., 2015; Aldo Córdova-Palomera et al., 2018; Davies et al., 2014; Dempster et al., 
2014; Malki et al., 2016; Oh et al., 2015; H Palma-Gudiel et al., 2019; Helena Palma-Gudiel et al., 
2018; Peng et al., 2018; Starnawska et al., 2019; Zhao et al., 2013; Zhu et al., 2019).
2.2. DNA methylation assessment
All the studies retrieved differ greatly in (i) the methodology employed to assess DNA 
methylation and (ii) the statistical approach used to identify epigenetic biomarkers. With regard 
to DNA methylation assessment, some authors performed hypothesis-free genome-wide DNA 
methylation association studies while others focused on candidate genes functionally relevant 
for depressive phenotypes. These strategies are each followed by specific downstream statistical 
pipelines. 
The genome-wide approach can be used to identify differentially methylated probes (DMPs), 
differentially methylated regions (DMRs), variably methylated probes (VMPs), methylation 
outliers and canonical gene pathways enriched for the DMPs, DMR and VMPs identified  (Rakyan 
et al., 2011). This kind of approaches require strict correction for multiple testing; however, due 
to the overall limited sample sizes assessed by the papers reviewed, most of the studies simply 
report top signals rather than genome-wide significant probes.
Candidate gene approaches allow to explore a specific region of interest more thoroughly. 
Pyrosequencing of target regions yields DNA methylation values for a number of contiguous CpG 
sites. This method allows both the identification of specific CpG sites involved in pathogenic 
pathways by means of CpG-specific analysis or the assessment of the overall methylation of the 
whole target region. Complementarily, some studies approach the study of candidate genes 
using genome-wide data  and focusing exclusively in the CpG sites located within the gene that 
are included in the array. However, this methodology generally leads to an infra-representation 
of the methylation landscape of a certain gene.
2.3. Clinical assessment
As for the assessment of depressive phenotypes, the papers reviewed have followed two main 
approaches: (i) assessment of lifetime prevalence of depressive disorders according to DSM (n 
= 9), or (ii) self-report of current depressive symptomatology (n = 5). While the former allows 
the comparison of affected versus non-affected co-twins of discordant pairs, the latter includes 
subjects with less severe forms of depressive symptomatology; however, by doing so, the 
epigenetic differences observed between co-twins reflect more qualitative aspects of 
psychopathology. Both approaches are complementary and help find different types of 
epigenetic biomarkers.
3. Results 
3.1. Genome-wide DNA methylation studies
As shown in Table 1, twin studies on DNA methylation and depression started with Byrne et al. 
(2013), and often include genome-wide analyses of tens or a few hundred subjects. The largest 
sample size analyzed to date was recently published by Starnawska et al. (2019), in a report on 
depressive symptoms from 724 twins from two cohorts. In many cases, authors analyze DNA 
methylation of peripheral tissues at the genome-wide level (mostly with Illumina DNA 
methylation arrays or Methylated DNA immunoprecipitation sequencing (MeDIP-Seq)). 
Half of the studies reviewed (n = 7) looked out for DMPs or DMRs in association with depression. 
While only one of them reported genome-wide significant DMPs (Starnawska et al., 2019), 
significant DMRs were identified by three independent studies (Davies et al., 2014; Starnawska 
et al., 2019; Zhu et al., 2019). Unfortunately, neither DMPs nor DMRs appear to replicate across 
studies. Nevertheless, a considerable proportion of the identified hits map to genes previously 
implicated in psychiatric disorders guaranteeing the use of twin studies in the field.
Similarly, network analysis by the different reports point to an enrichment of gene pathways 
involved in either nervous system development and function (e.g. “dopaminergic synapse”, 
“neuron apoptotic process”), metabolic (e.g. “lipid metabolic process”), immune (e.g. 
“interleukin-2-mediated signaling events”) and neuroendocrine processes (e.g. “rapid 
glucocorticoid signaling”), fitting with the different etiological hypotheses for depression. 
3.2. Candidate gene studies
On the other hand, studies of candidate genes/loci generally do not require dedicated multiple 
testing correction strategies, although it is still important to conduct analysis protocols that 
consider the technical limits of detection. The five candidate gene studies included in this review 
assessed DNA methylation at: solute carrier family 6 member 4 (SLC6A4), monoamino oxidase 
A (MAOA) and B (MAOB), nuclear receptor subfamily 3 group C member 1 (NR3C1), brain-
derived neurotrophic factor (BDNF), DEP domain containing 7 (DEPDC7), and serine/threonine 
kinase 32C (STK32C) genes. 
SLC6A4 encodes the serotonin transporter, involved in serotonin reuptake from the synaptic 
cleft, which is the pharmacological target of selective serotonin reuptake inhibitors (SSRI), a 
widely prescribed antidepressant type. SLC6A4 methylation has been repeatedly assessed with 
regard to exposure to stress and subsequent development of different psychiatric disorders 
(Palma-Gudiel & Fañanás, 2017). Three of the studies reviewed focused on SLC6A4 methylation 
revealing its association with depressive (Peng et al., 2018; Zhao et al., 2013) and somatization 
(Palma-Gudiel et al., 2019) symptomatology.
Similarly, MAOA and MAOB genes encode two different variants of the monoamine oxidase 
enzyme, a key component of the monoamine degradation pathway. Thus, they are involved in 
dopaminergic, noradrenergic and serotoninergic neurotransmission, which makes candidate 
genes for psychiatric disorders (Ziegler & Domschke, 2018). One of the studies reviewed 
reported MAOA, but not MAOB, methylation to be associated with depressive symptomatology 
(Peng et al., 2018).   
NR3C1 encodes the glucocorticoid receptor, key player in initiation and termination of the stress 
response. NR3C1 methylation has been previously linked with early life stress while his role in 
the etiology of stress-related disorders is currently under investigation (Palma-Gudiel et al., 
2015). Two of the studies reviewed assessed NR3C1 methylation supporting its role in 
depressive etiology and brain connectivity (Palma-Gudiel et al., 2018; Peng et al., 2018). 
BDNF encodes a neurotrophic factor that promotes neuronal differentiation, dendritic growth, 
brain cell survival and proliferation, among others. Genetic variability at this gene (and Val66Met 
polymorphism in particular) has been traditionally linked to neurodegenerative and psychiatric 
disorders. More recently, BDNF methylation has also been explored, suggesting its role on 
schizophrenia pathogenesis, with a less clear role in depression (Zheleznyakova et al., 2016). 
One of the papers reviewed reported BDNF methyhlation to be associated with depressive 
symptomatology (Peng et al., 2018).
Finally, while DEPDC7 and STK32C functions remain unclear, they were targeted in one of the 
studies reviewed as CpG-specific differential methylation at both genes was the more robust 
finding in one of the genome-wide DNA methylation approaches (Dempster et al., 2014). 
Examination of both CpG sites in an independent twin sample revealed replication of the 
association between DEPDC7, but not STK32C, methylation and depressive symptomatology 
(Córdova-Palomera et al., 2015).
4. Discussion
4.1. Strengths of the twin study design to explore DNA methylation
While the use of moderate sample sizes in virtually all studies warrants the need for replication 
to validate the findings, it is important noting that the research community has implemented 
different analytical approaches to gain statistical power while accounting for different features 
of the methylation assays. For instance, Byrne et al. (2013) used a permutation-based approach 
to establish significance of their top results, while reports published by Dempster et al. (2014), 
Córdova-Palomera et al. (2015b) and other authors take into account both statistical significance 
of group differences (e.g., p-value) as well as magnitude of the changes (e.g., absolute  
Noteworthy, by integrating statistical significance and magnitude, the latter approach has 
advantages such as filtering results from probes with small variability within the study 
population (analogous to monomorphic sites in the DNA sequence), as well as removing probes 
with methylation differences close to the technical detection limits of the study platforms. 
In the same vein, a subset of studies explored the role of DNA methylation variability within the 
depressed group rather than searching for absolute significant DNA methylation differences 
between groups (Figure 3). All of them reported higher DNA methylation variability and higher 
number of DNA methylation outliers in depressed subjects when compared to controls (Byrne 
et al., 2013; Aldo Córdova-Palomera et al., 2018; Dempster et al., 2014; Oh et al., 2015). In this 
context, methylation outliers could operate like copy number variants of very low frequency in 
the population but outstanding penetrance. Thus, identified CpG probes with outlying 
methylation signatures only in one of the co-twins of a pair can be useful for the identification 
of new pathways involved in the pathogenesis of depression.
With regard to study design, the use of self-reported symptomatology by means of 
questionnaires, such as the Brief Symptom Inventory (BSI) or the Beck Depression Inventory 
(BDI), instead of categorical diagnoses based on DSM criteria yields quantitative continuous 
scores to be used as dependent variables of the analysis, thus increasing the statistical power of 
the sample. The lack of dichotomic subgroups allows to estimate intrapair differences for both 
variables of interest and test how they interact (figure 3).
Downstream statistical pipelines greatly differ between the studies reviewed. Our research 
group has explored some of the possibilities that can only be developed in datasets 
encompassing not only discordant pairs but also concordant (i.e. both twins of a pair affected 
by the trait of interest) and healthy (none of the twins of a pair affected by the trait of interest) 
twin pairs. As displayed in Figure 3a, mean twin pair methylation, intrapair methylation 
difference and methylation outliers that are specific to the discordant pairs but not the 
concordant or healthy ones are just some of the strategies explored in the UB Twin Registry 
(Córdova-Palomera et al., 2018, 2015a, 2015b; Palma-Gudiel et al., 2019; Palma-Gudiel et al., 
2018). Specifically, the use of mean intrapair methylation allowed us to detect a familial 
hypermethylation in the NR3C1 gene further associated with hippocampal connectivity; such 
findings were circumscribed to concordant pairs of our sample contributing to explain the 
heterogeneity of the depressive phenotype (Helena Palma-Gudiel et al., 2018). 
4.2. Limitations of studies reviewed
General limitations of human DNA methylation studies apply to the papers reviewed herein. 
First, observational cross-sectional studies do not allow to establish causality regarding the 
identified DNA methylation changes. Thus, the correlational nature of the findings implies that 
either DNA methylation precedes psychopathology or appears afterwards as a downstream 
consequence of the symptoms; this phenomenon is also known as reverse causation (Tobi et al., 
2018). Similarly, pharmacological treatment for depression might also influence the DNA 
methylation landscape (Csoka & Szyf, 2009); thus, studies focusing on current sub-threshold 
symptomatology rather than categorical diagnoses can help find the genuine biomarkers of 
disease.  All the studies analyzed DNA methylation in peripheral tissues, mainly peripheral blood; 
although brain tissue appears as the most relevant source to explore psychiatric disorders, it 
remains inaccessible in human studies; however, neuroendocrine and immune components of 
the depressive phenotype are likely to be biologically programmed in peripheral tissues (Raison 
& Miller, 2017). Alternatively, correlation of DNA methylation levels across tissues, specifically 
blood and brain, can be ascertained thanks to available online tools (Hannon et al., 2015). All 
studies were developed in populations of European descent, calling into question the 
generalizability of reported findings to other ethnic groups (Zhang et al., 2011); epigenetic 
estimation  of chronological age has been already reported to differ as a function of ethnicity 
(Horvath et al., 2016). 
One of the challenges of epigenetic epidemiology is the technical difficulty to access specific cell 
types (Teschendorff & Zheng, 2017). This is reflected in the fact that multiple research reports 
include peripheral tissues with mixed cell types, with each cell type potentially contributing 
different epigenetic signatures. One of the ways of mitigating this type of confounding is by 
accounting for cell mixture proportions with in silico methods (e.g., Houseman et al. 2012), 
although this is not yet a widespread practice among the community.
Further limitations specific to genome-wide studies include the use of commercially available 
platforms such as the widely used Illumina arrays (Moran et al., 2015; Sandoval et al., 2011). 
Since these arrays have been enriched in cis-acting promoters and CpG islands, they lack power 
to detect methylation changes in other putatively relevant regions, such as trans-acting 
promoters or distal regulatory regions (Pidsley et al., 2016).
5. Future directions
Despite the discussed caveats, epigenetic twin studies hold promise in the field of psychiatric 
epigenetics. Thanks to genetically informative designs and the removal of a great number of 
potential confounders, twin studies provide the opportunity to test epigenetic hypotheses in 
psychiatric disorders in resource-limited settings. Smaller sample sizes are sufficient to yield 
promising hits in proof-of-concept studies that can be later replicated in bigger more 
representative samples (Sugawara et al., 2011; Tsai & Bell, 2015). 
As summarized in Figure 3, twin studies offer different alternative to tackle the issue. Although 
one of the most intuitive strategies is to measure intrapair differences for the predictors and/or 
outcomes of interest in twin pairs discordant for the trait under study, both concordant and 
healthy twin pairs can be incorporated in more nuanced analyses (Fig. 3A). Likewise, a certain 
complex trait can also be explored from different points of view; e.g. categorical diagnosis of 
major depression and depressive symptomatology scores will yield different findings. Besides 
the phenotypical level of analysis, the DNA methylation analysis can be either (i) targeted or 
hypothesis-free, (ii) CpG- or region-specific, (iii) based on absolute differences or on variability 
rates, among other variations in the analysis strategy (Fig. 3B).
While the focus of the present systematic review was to evaluate the usefulness of twin study 
designs in the search for epigenetic biomarkers of depression, the different analytical strategies 
described herein can be extended to other biological correlates and other diseases as well. In 
fact, twin studies have also shed some interesting results in fields as diverse as transcriptomics 
and neuroimaging (Córdova-Palomera et al., 2017; Saffari et al., 2019). Integration of gene 
expression, epigenetic patterns and brain connectivity in a single model will surely contribute to 
a better understanding of the physiopathology of depression and other complex disorders.
In order to overcome the peripheral source of biological samples aimed for DNA extraction and 
methylomic profiling, the developing of brain organoids from discordant twin subjects could 
help elucidate the epigenetic changes present in nervous tissue in association with depression 
and other psychiatric and neurologic disorders (Luo et al., 2016). Since exposure to stressful and 
traumatic events plays an essential role in the etiology of depression, incorporating 
environmental threats into genome-wide DNA methylation studies is mandatory to unravel the 
mechanistic insights of hypothesized gene – environment interactions. Preliminary candidate 
gene twin studies have already revealed the usefulness of longitudinal twin designs to dissect 
the dynamics of DNA methylation changes after trauma (Ouellet-Morin et al., 2013). 
Recent developments in the epigenetic field emphasize the utility of computing polyepigenetic 
scores, paralleling polygenic risk scores developed from genome-wide association studies, as 
summary measures of exposure to stress and smoking (Provençal et al., 2019; Sugden et al., 
2019). Following these pioneering studies, MZ twins discordant for depression might contribute 
in the estimation of new epigenetic biomarkers of vulnerability for depression.     
Finally, most of the papers reviewed have taken advantage of already established twin registries 
in Europe (UK, Denmark, The Netherlands and Spain), USA and Australia. The promising findings 
obtained so far highlight the importance of establishing such big cohorts of MZ twins and the 
need to merge available datasets to improve the power of the analysis. In this regard, Malki et 
al. (2016) describe several strategies to reduce noise and unwanted variance to optimize data 
consolidation in studies encompassing samples from independent datasets.
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FIGURE CAPTIONS
Figure 1. Path diagram for the basic univariate twin model. The phenotype of each twin is 
decomposed into A, C and E variance components corresponding to additive genetics (A), 
common (shared) environment (C) and unique (non-shared) environment (E), respectively. MZ 
twins are assumed to share 100% of their genetic sequence while DZ twins share an approximate 
50%. Abbreviations: DZ, dizygotic; MZ, monozygotic.
Figure 2. Flow diagram summarizing the systematic search performed. Sixty-eight records were 
excluded through title and abstract screening including 41 reviews, 5 book chapters, 1 editorial, 
2 comments, 2 study designs, 1 opinion article and 16 research papers in which either depressive 
phenotypes or DNA methylation were not assessed.
Figure 3. Analytical strategies to explore epigenetics of depression in twin study designs. 
Different approaches can be developed according to (a) sample subsetting and (b) downstream 
statistical analysis. (a) Twins of a pair can either be concordant, discordant or healthy for a 
disease of interest as a function of whether both, one or none of the twins of a pair is affected, 
respectively. While comparisons between twins of discordant pairs (right arrow) allow the 
calculation of intrapair differences in genetically identical individuals, comparison between 
different types of twin pairs according to concordance (left arrow) provide an opportunity to 
explore familiality of traits and different degrees of severity. (b) The left panel illustrates the 
possibility to focus the analysis in functional candidate genes (e.g. due to their involvement in 
serotoninergic neurotransmission) or perform hypothesis-free genome-wide approaches; right 
panel displays  different opportunities derived from genome-wide studies, which include (i) 
differential vs variable methylation, (ii) exploration of individual probes vs regions, and (iii) gene 
pathway analysis.
Abbreviations: DMP (differentially methylated position); MWAS (methylome-wide association 
study); VMP (variably methylated position).
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